ATE28566T1 - Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. - Google Patents
Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.Info
- Publication number
- ATE28566T1 ATE28566T1 AT83400458T AT83400458T ATE28566T1 AT E28566 T1 ATE28566 T1 AT E28566T1 AT 83400458 T AT83400458 T AT 83400458T AT 83400458 T AT83400458 T AT 83400458T AT E28566 T1 ATE28566 T1 AT E28566T1
- Authority
- AT
- Austria
- Prior art keywords
- amine
- immunotoxin
- cell
- pct
- product containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8204119A FR2536997B1 (fr) | 1982-03-11 | 1982-03-11 | Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine |
EP83400458A EP0089270B1 (de) | 1982-03-11 | 1983-03-07 | Zellgiftiges Arzneimittel enthaltend mindestens ein Immunotoxin und ein Amin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE28566T1 true ATE28566T1 (de) | 1987-08-15 |
Family
ID=9271880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT83400458T ATE28566T1 (de) | 1982-03-11 | 1983-03-07 | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4614650A (de) |
EP (1) | EP0089270B1 (de) |
JP (1) | JPS59500371A (de) |
AT (1) | ATE28566T1 (de) |
DE (1) | DE3372708D1 (de) |
FR (1) | FR2536997B1 (de) |
WO (1) | WO1983003200A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2516794B1 (fr) * | 1981-11-20 | 1985-10-25 | Sanofi Sa | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique |
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
FR2573656B1 (fr) * | 1984-11-29 | 1987-02-27 | Sanofi Sa | Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose |
US4689401A (en) * | 1986-03-06 | 1987-08-25 | Cetus Corporation | Method of recovering microbially produced recombinant ricin toxin a chain |
JP2006100141A (ja) * | 2004-09-29 | 2006-04-13 | Toshiba Corp | 付臭剤、燃料電池用液体燃料及び燃料電池 |
GB0507672D0 (en) * | 2005-04-15 | 2005-05-25 | Barnaba Vincenzo | Adjuvant |
JP4444355B2 (ja) * | 2008-09-03 | 2010-03-31 | 株式会社東芝 | 燃料電池 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2466252A2 (fr) * | 1979-10-03 | 1981-04-10 | Clin Midy | Nouveaux produits ayant notamment des proprietes anticancereuses a base de chaine a de la ricine et d'une proteine |
JPS57197223A (en) * | 1981-05-27 | 1982-12-03 | Eisai Co Ltd | Immunoenhancing agent containing ricin b chain |
US4489710A (en) * | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
FR2516794B1 (fr) * | 1981-11-20 | 1985-10-25 | Sanofi Sa | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique |
US4485093A (en) * | 1982-08-13 | 1984-11-27 | Runge Richard G | Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer |
-
1982
- 1982-03-11 FR FR8204119A patent/FR2536997B1/fr not_active Expired
-
1983
- 1983-03-07 JP JP58500925A patent/JPS59500371A/ja active Granted
- 1983-03-07 EP EP83400458A patent/EP0089270B1/de not_active Expired
- 1983-03-07 US US06/557,148 patent/US4614650A/en not_active Expired - Fee Related
- 1983-03-07 WO PCT/FR1983/000043 patent/WO1983003200A1/en unknown
- 1983-03-07 AT AT83400458T patent/ATE28566T1/de not_active IP Right Cessation
- 1983-03-07 DE DE8383400458T patent/DE3372708D1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0089270A1 (de) | 1983-09-21 |
EP0089270B1 (de) | 1987-07-29 |
WO1983003200A1 (en) | 1983-09-29 |
US4614650A (en) | 1986-09-30 |
JPH0455173B2 (de) | 1992-09-02 |
FR2536997B1 (fr) | 1987-08-07 |
JPS59500371A (ja) | 1984-03-08 |
DE3372708D1 (en) | 1987-09-03 |
FR2536997A1 (fr) | 1984-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE862554L (en) | Pharmaceutical compositions | |
OA09772A (en) | "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". | |
ATE2667T1 (de) | Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus. | |
UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
DE3770730D1 (de) | Antikrebstherapie und zytotoxische arzneimittel fuer deren implementation. | |
GR3017282T3 (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them. | |
SE8700499D0 (sv) | Novel pharmacologically active compounds | |
PL297399A1 (en) | Masked taste pharmaceutical preparations | |
ITRM910696A0 (it) | Composizioni farmaceutiche per l'applicazione per via nasale. | |
GR3023638T3 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
FR2677984B1 (fr) | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
IT1212778B (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
ATE28566T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. | |
MY114282A (en) | Anthracycline derivatives | |
DK0443848T3 (da) | Nyt antiulcermiddel | |
IL67940A0 (en) | 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them | |
DE68920896D1 (de) | N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung. | |
EP0515995A3 (en) | N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them | |
MX9203361A (es) | Composiciones farmaceuticas que contienen cloruro de galio. | |
ATE20519T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und chloroquin. | |
ZA81927B (en) | Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds | |
IL97321A0 (en) | Diamine derivatives,their manufacture and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |